Lyndra is a biopharmaceutical company that focuses on the development of long-acting oral therapies. Their proprietary technology platform aims to transform the administration of oral medications, enabling extended-release formulations that can last for a week or more.

Lyndra

Established in 2015, Quark Venture is focused on equity financing of innovative biotechnology and health sciences companies with breakthrough technology platforms and projects.
 
Our strategic goal is to support and enable companies we invest in to grow, create value and be successful by providing not only financial support, but also developmental, infrastructure and expertise support, as needed, through our global network.
 
Our approach is to establish long-term relationships with target companies, with a view to enable and strengthen management to realize the full potential and value of the technology. This approach has previously been successfully demonstrated in the energy and high-tech sectors where Quark Venture partners have invested.
 
While Quark Venture is headquartered in Vancouver, it has offices in Boston, Hong Kong and Chengdu, and plans to establish a European office in 2017.

Metric
Company Name	Lyndra
Symbol
MSH ID	COM:QUARKVENTURE
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biopharmaceuticals
Country	CA
Stage
Employee Count	5
Website	quarkventure.com
LinkedIn	quarkventure
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score	10.36
28-Day Growth Score	16.39
90-Day Growth Score	14.09
365-Day Growth Score	13.03

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:QUARKVENTURE

Lyndra

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue